Diabetes that develops after acute pancreatitis
Epidemiology and Pathophysiology of Acute Pancreatitis-related Diabetes Mellitus
This project follows people who've had acute pancreatitis to find out why and how often they develop diabetes.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-11234780 on NIH RePORTER |
What this research studies
If you join, you'll be followed after an episode of acute pancreatitis with regular blood tests and health checks to see if and when diabetes appears. The study is part of a multi-center consortium with leadership from Ohio State and collects blood samples, medical records, diet information, scans, and other data over several years. Researchers will look for signs of autoimmunity, pancreatic damage, and dietary or metabolic factors that might explain why diabetes develops in some people but not others. The goal is to use these repeated tests and data to help doctors spot high-risk patients earlier and design better prevention or treatment strategies.
Who could benefit from this research
Good fit: Adults who recently had an episode of acute pancreatitis and can attend periodic follow-up visits and blood tests are ideal candidates.
Not a fit: People whose diabetes began before their pancreatitis or who cannot complete follow-up visits and testing are unlikely to benefit directly.
Why it matters
Potential benefit: Could identify who is at highest risk for diabetes after pancreatitis so they can receive earlier monitoring, prevention, or tailored treatment.
How similar studies have performed: Previous smaller or retrospective studies suggest post-pancreatitis diabetes is common but were limited, so this prospective multi-center effort is a newer, more comprehensive approach.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Papachristou, Georgios I — Ohio State University
- Study coordinator: Papachristou, Georgios I
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.